Evidence map›Paper›PMID 37885785›Full record

ArticleBioinformation2023

Permafrost viremia and immune tweening.

Jaden Penhaskashi, Olivia Sekimoto, Francesco Chiappelli

Abstract read
In one paragraph

Article in Bioinformation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Regulation of inflammaging.Bioinformation · 2025
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jaden PenhaskashiDivision of West Valley Dental Implant Center, Encino, CA 91316, USA.
Olivia SekimotoCajulis Pediatric Dentistry, Chula Vista, CA 91914, USA.
Francesco ChiappelliDental Group of Sherman Oaks, CA 91403 , USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immune system, an exquisitely regulated physiological system, utilizes a wide spectrum of soluble factors and multiple cell populations and subpopulations at diverse states of maturation to monitor and protect the organism against foreign organisms. Immune surveillance is ensured by distinguishing self-antigens from self-associated with non-self (e.g., viral) peptides presented by major histocompatibility complexes (MHC). Pathology is often identified as unregulated inflammatory responses (e.g., cytokine storm), or recognizing self as a non-self entity (i.e., auto-immunity). Artificial intelligence (AI), and in particular specific machine learning (ML) paradigms (e.g., Deep Learning [DL]) proffer powerful algorithms to better understand and more accurately predict immune responses, immune regulation and homeostasis, and immune reactivity to challenges (i.e., immune allostasis) by their intrinsic ability to interpret immune parameters, pathways and events by analyzing large amounts of complex data and drawing predictive inferences (i.e., immune tweening). We propose here that DL models play an increasingly significant role in better defining and characterizing immunological surveillance to ancient and novel virus species released by thawing permafrost.

Indexed as

Autologous Immune Enhancement TherapyB cell immunityCD25 (α-chain of the interleukin[IL]2 receptor, marker of T cell activation)CD279 (programmed cell death marker-1)CD45R0 (marker of immune cell memory differentiation: ultimate restriction fragment [0] of the common leukocyte antigenCD45RA (marker of naive CD4 and CD8 T cellsCD62L (l-selectin, marker of T cells migration)cluster of differentiation [CD]45)Deep Ensemble LearningDeep Learningfirst restriction fragment [A] of CD45)Generative Adversarial NetworksGlycA (glycoprotein acetylation, systemic biomarker of systemic inflammation and autoimmunity)Immune tweeningInflammationMachine LearningMolecular Dynamics SimulationNeuronal NetworksPermafrost pathogensT cell immunityTcR[αβ](T cell receptor endowed with the α and β chains)Tim-3 (T cell immunoglobulin and mucin domain 3)Tracking Responders EXpandingTRegs (CD4/8+CD45RA+/R0+FoxP3+)Viremia

Identifiers

PMID37885785
PMCPMC10598357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.